Wearable health technology company Katalyst has raised $26 million in series A funding.
Katalyst makes FDA-approved full-body, wearable electro muscle stimulation products used for health and fitness. The company plans to use the new funding to scale production, develop its brand and hire new employees, according to the Oct. 4 Katalyst news release.
"As an industry, we've struggled to innovate in ways that actually empower the vast majority of our population to live longer, healthier, and happier lives," Katalyst founder and CEO Bjoern Woltermann said. "Katalyst eliminates the external loads and physical wear associated with conventional workouts, as well as the significant time required, making fitness easier, faster, safer, and more effective than ever before. I was first introduced to full-body EMS training in Germany in 2012, and I realized immediately that this technology, outside the confines of a physical studio, had the potential to significantly improve quality of life and overall well-being on a mass scale."